BOSTON (Thomson Financial) - GenVec Inc. Wednesday said it received a grant valued at $546,000 over two-years from the National Eye Institute to explore mechanisms regulating pigment epithelium-derived factor, a key regulator of blood vessel growth in the eye.
The company said the research conducted under the grant may lead to the discovery and testing of improved strategies to treat neovascular diseases of the eye.
Shares of the Gaithersburg, Md.-based biopharmaceutical company closed Tuesday at $1.72. Casey Logan cl/pc COPYRIGHT Copyright Thomson Financial News Limited 2007. All rights reserved. The copying, republication or redistribution of Thomson Financial News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Financial News.
© 2008 AFX News
